Albany, NY -- (SBWIRE) -- 01/19/2016 -- According to a new market research report published by Transparency Market Research Parenteral Nutrition Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023" the global parenteral nutrition market was valued at US$4.1 bn in 2014 and is estimated to reach a market value of US$6.9 bn by 2023 expanding at a CAGR of 5.7% from 2015 to 2023.

Browse the full Parenteral Nutrition Market (By Type of Nutrient - Carbohydrates, Parenteral Lipid Emulsions, Single Dose Amino Acid Solutions, Trace Elements and Vitamins and Minerals) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/parenteral-nutrition-market.html

Parenteral nutrition (also known as intravenous feeding) is a method for the administration of nutritional supplement into the body through vein. Parenteral nutrition is used for the patients who cannot receive their nutrition requirements orally or have a non-functional gastrointestinal tract. Parenteral nutrition is commonly indicated for the patient's with short bowel syndrome, crohn's disease, ischemic bowel disease, cancer, diabetes and others. The market for parenteral nutrition is witnessing positive growth owing to the rising incidence of chronic disorders such as gastro-intestinal disorders, cancer, short bowel syndrome, ischemic bowel disease, Crohn's disease, and renal failure. For example, according to the World Health Organization (WHO), cancer accounted for the leading cause of morbidity and mortality globally, with around 14 million new cases in 2012. The organization stated that new cancer cases are expected to increase by 70% till 2025 to 2035. Thus, rising number of patients affected with chronic diseases fuels the demand for parenteral nutrition, leading to the market growth. However, side effects such as Catheter-related bloodstream infection, liver dysfunction and others with parenteral nutrition hamper the market growth to some extent. The global parenteral nutrition market was valued at US$ 4,097.4 Mn in 2014 and is expected to reach US$ 6,874.1 Mn by 2023, expanding at a CAGR of 5.7% from 2015 to 2023.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611

Based on type of nutrient, the global parenteral nutrition market has been segmented into carbohydrates, parenteral lipid emulsions, single dose amino acid solutions, trace elements and vitamins and minerals. The market of carbohydrates captured more than 23.0% share of the global parenteral nutrition market in 2014. Rinsing use of dextrose as parenteral nutrition for premature babies is considered as the major driving factor for the growth of this segment. Single dose amino acids accounted for the largest share of the global parenteral nutrition market owing to the rising approval of novel single dose amino acid parenteral products by regulatory authorities. Parenteral lipid emulsion is projected to growth at the highest CAGR due to rising demand for this nutrient as it offers potential benefits as drug delivery vehicle. For example, administration of lipid emulsions act as essential drug carriers that results in reduced pain, irritation, and prevention of thrombophlebitis.

Based on geography, the market for parenteral nutrition market has been segmented as North America, Europe, Asia Pacific, Latin America and Middle East and Africa (MEA). Developed regions such as North America and Europe collectively accounted for majority of market share, captured almost 68% share of the total parenteral nutrition market. Factors such as approval of new parenteral formulations, rise in geriatric population and increasing chronic disorders augments the market growth in these regions. Parenteral nutrition market in Middle East and Africa accounted for the lowest revenue of the total market. Lowest growth of the segment is primarily witnessed due to shortage or parenteral nutrition products coupled with limited promotional activities by key market players.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/parenteral-nutrition-market.htm

The global parenteral nutrition market is consolidated in which relatively small number of companies accounted for majority of market share. Companies such as Baxter International, Inc., Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Hospira, Inc., Grifols S.A., Claris LifeSciences Limited and others are some of the key players having presence in the global parenteral nutrition market.

The global parenteral nutrition market is segmented as follows:
Global Parenteral Nutrition Market, By Type of Nutrient
Carbohydrates
Parenteral Lipid Emulsion
Single Dose Amino Acid Solutions
Trace Elements
Vitamins and Minerals
Global Parenteral Nutrition Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Taiwan
South Korea
Rest of APAC
Latin America (LATAM)
Argentina
Mexico
Rest of LATAM
Middle East and Africa (MEA)
Turkey
Rest of MEA

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/